Sbi Securities Co., Ltd. Acurx Pharmaceuticals, Inc. Put Options Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACXP
# of Institutions
36Shares Held
2.66MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$7.52 Million0.01% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$2.56 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$1.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$1.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY106KShares$740,2200.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $80.5M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...